Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €57.78 EUR
Change Today +0.168 / 0.29%
Volume 1.5M
FRE On Other Exchanges
Symbol
Exchange
Xetra
OTC US
OTC US
Xetra
As of 3:50 PM 06/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

D. Michael Albrecht

Member of Supervisory Board, Fresenius SE & Co KGaA
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 1 different industries.

See Board Relationships
--€180,000

Background*

Prof. Dr. Med. D. Michael Albrecht serves as Medical Director and spokesman of the Management Board of the Universitätsklinikum Carl Gustav Carus Dresden. Prof. Dr. Med. Albrecht has been a Member of the Supervisory Board at Fresenius SE & Co KGaA since January 28, 2011.

Corporate Headquarters*

Else-Kröner-Strasse 1
Bad Homburg, Hessen 61352

Germany

Phone: 49 6172 6080
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation€180,000
Total Calculated Compensation€180,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FRE:GR €57.78 EUR +0.168

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kent J. Thiry Chairman of the Board, Chief Executive Officer and Chief Executive Officer of Healthcare Partners
DaVita HealthCare Partners Inc.
$1.2M
Brian P. Concannon Chief Executive Officer, President and Director
Haemonetics Corporation
$640.2K
Benson F. Smith Chairman, Chief Executive Officer, President and Member of Non-Executive Equity Awards Committee
Teleflex Incorporated
$866.7K
Stefan A. Dräger Owner of Drägerwerk Verwaltungs AG, Chairman of Executive Board - Drägerwerk Verwaltungs AG and Chief Executive Officer of Drägerwerk Verwaltungs AG
Dragerwerk AG & Co. KGaA
€754.0K
Sumiya Hori Chairman and Chief Executive Officer
Yakult Honsha Co. Ltd.
¥150.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FRESENIUS SE & CO KGAA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.